Remarkably, pathways in cancer including PI3K‐Akt signalling, focal adhesion, ECM‐receptor interaction, antigen processing and phagosome were activated in tumour with low SLC12A5 expression (Figure 4C). This evidence concerns the gene AKT1 and cancer.